Clinical Senior Lecturer @dundeeuni | Medical Oncology Consultant | Research - frailty & precision medicine in UGI/HPB cancers | @ManUtd fan
Joined August 2015
- Tweets 265
- Following 961
- Followers 654
- Likes 3,379
26 Photos and videos
13 Jun 2025
An excellent programme with fantastic talks! Inspiring to see the cross speciality work on frailty π Thanks to @colki1983 and @DrTerryQuinn the invitation to speak on Supporting Older Adults with Cancer.
@JGeriOnc @SIOGorg @YoungSIOG
Thank you to everyone who joined Frailty Conference today. Thanks also to all our speakers, session chairs and sponsors.
@GeriSoc @colki1983
3
3
19
975
12 Jun 2025
Excellent session at #UKOF25 focused on Older Adults with Cancer, highlighting the current challenges and models of care in the UK.
@kwokleungcheung @EtienneB66 @DrKirstyB @jenny_welford @JGeriOnc @YoungSIOG @siognah
1
2
24
716
12 Jun 2025
The #UKOF25 treating the older cancer patient session has begun with @EtienneB66 giving an excellent update on trials in older adults and emerging data from ASCO! @JGeriOnc @YoungSIOG @siognah
10
297
Mark Baxter retweeted
31 Mar 2025
Fourth year @UoDMedicine student Cyril Kocherry presenting his research on brain metastases in Oesophageal cancer at UKIOG- in the setting of modern treatments the incidence may be higher than we previously anticipated.
Great work- ππππ
@majbaxter @NHSTayside
1
2
15
542
6 Jan 2025
Fantastic to see another @onctrainees project published!
The TOURISM study (Treatment Outcomes in UteRIne SarcoMa) was a UK-wide study with the goal of reporting patient characteristics, treatment strategies and outcomes in this rare tumour type.
@UoDMedicine @NHSTayside
6 Jan 2025
So happy to share the latest study from @onctrainees led by Dr Karen Mactier from @NHS_Lothian @UofGlasgow, looking at UK-wide practice in managing a rare cancer, uterine sarcoma.
πππ
pubmed.ncbi.nlm.nih.gov/3972β¦
1
8
652
Mark Baxter retweeted
26 Sep 2024
π£ UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
Read new #OriginalResearch from @majbaxter and colleagues: bmjoncology.bmj.com/content/β¦
@onctrainees @HelenDearden3 @michaelroweuk2 @DrSallyMartin @OncoAlert #OncoAlert
4
11
838
16 Sep 2024
16 Sep 2024
International Oesophagogastric TNT Group presentation today by @MissHClements at #ESMO24
N=140 pts from π¬π§πΊπΈπ¨π¦πΊπ¦π±πΉ
Total Neoadjuvant FLOT( 8 cycles) can be delivered safety & shows encouraging survival outcomes despite the advanced stage of the patient cohort
@myESMO
1
4
479
Mark Baxter retweeted
14 Sep 2024
Team UK ESMO football team π¬π§ππ»
#ESMO2024 @MelanomaPod @cdanicas @DrSapnaPatel @royalmarsdenNHS @DuncanGilbert11 @Adam_Hexter
5
4
20
3,151
Mark Baxter retweeted
3 Sep 2024
Cancer tool "unable to accurately predict" toxicity levels in UK patients: new methods to determine which older adults with cancer will tolerate chemotherapy must be developed to improve treatment decisions, a University of Dundee expert has said. buff.ly/4e9DSfY
3
14
684
30 Aug 2024
339 eligible patients were recruited from 19 UK sites:
β‘οΈ Median age 73 years (range 65β92)
β‘οΈ 59.1% ECOG PS 1
β‘οΈ Median Rockwood CFS was 3 (range 0β8)
β‘οΈ Median G8 was 12 (range 6β16)
Only 21 (6.2%) patients had a formal baseline frailty assessment as standard of care
4/9
1
1
252
30 Aug 2024
In summary, in a UK pop of older adults receiving 1st line CTx:
β‘οΈ Frailty is prevalent
β‘οΈ ~1/4 develop at least one severe toxicity
β‘οΈ ~1/4 have a hospital admission
β‘οΈ CARG Score was not validated
Importantly patient/clinician perceptions of risk differ significantly!
1
1
232
30 Aug 2024
This study was a monumental effort from the @onctrainees trainees involved - no funding or protected time was received & planning began (led by @HelenDearden3) in 2017 with recruitment over 2 years!
Finally, we must also thank the patients and families who took part.
9/9
2
5
497
14 Aug 2024
Thank you @RussellPetty19 @PeterHall001 Prof Chim Lang @TASC_Research for your support in obtaining the @CSO_Scotland EPD Fellowship.
We will investigate the impact of age, co-morbidity & frailty on cancer outcomes in older adults.
@UoDMedicine @YoungSIOG @SIOGorg @NHSTayside
14 Aug 2024
ππI am delighted that my medical oncology colleague @majbaxter has been awarded a prestigious @CSO_Scotland post doctoral fellowship to investigate multi-morbidity and frailty in the aging cancer population. Dundee Medical Oncology in the ascendancy!
Congratulations Mark!ππ
5
36
1,691
1 Jul 2024
πWellcome Trust Multimorbidity PhD opportunity in Geriatric Oncology commencing August 2025 π
Any questions, please get in touch!
gla.ac.uk/postgraduate/doctoβ¦
@UoDMedicine @RussellPetty19 @PeterHall001 @YoungSIOG @onctrainees
16
19
1,852